Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy

scientific article published in September 1999

Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1365-2893.1999.00184.X
P698PubMed publication ID10607253

P50authorFerruccio BoninoQ37828551
Gioacchino LeandroQ42705700
P2093author name stringG Mancia
M R Brunetto
G Bellati
G Idéo
F Bissoli
L Roffi
G Colloredo
A Scalori
B Brugnetti
E Civardi
P2860cites workClassification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 regionQ27861003
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitisQ29619627
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sourcesQ29620774
Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.Q34377809
Side effects of alpha interferonQ38745781
Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatmentQ39507207
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control studyQ42980911
Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.Q42980987
Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapyQ42982517
Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alphaQ42982978
Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis CQ42984730
Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparisonQ42985824
Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detectionQ43035211
Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis CQ43038103
Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferonQ43040128
Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapyQ43040510
Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferonQ43041718
Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.Q43049010
Clinical outcomes after transfusion-associated hepatitis C.Q44746801
The long-term pathological evolution of chronic hepatitis C.Q44765507
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).Q45852358
A proposed system for the nomenclature of hepatitis C viral genotypesQ57205742
Interferon for non-A, non-B chronic hepatitisQ58803541
P433issue5
P921main subjectHepatitis C virusQ708693
P304page(s)373-380
P577publication date1999-09-01
P1433published inJournal of Viral HepatitisQ15749962
P1476titlePrediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy
P478volume6

Search more.